Quick search Find article
Quick search
Find article

Biological imaging in radiation therapy: role of positron emission tomography

FEATURED ARTICLE REVIEW ARTICLE

Ursula Nestle1, Wolfgang Weber2, Michael Hentschel1 and Anca-Ligia Grosu1

Show affiliations


 
Abouzied M M, Crawford E S and Nabi H A 2005 18F-FDG imaging: pitfalls and artifacts J. Nucl. Med. Technol. 33 145-55 quiz 162-3
PubMed 
 
Alber M, Paulsen F, Eschmann S M and Machulla H J 2003 On biologically conformal boost dose optimization Phys. Med. Biol. 48 N31-5
IOPscience 
 
Baum R P, Hellwig D and Mezzetti M 2004 Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancer Q J. Nucl. Med. Mol. Imaging 48 119-42

 
Bayne M, MacManus M, Hicks R, Leong T, Peters L and Ball D 2005 Can a mathematical formula help define a radiation target volume using positron emission tomography? In regard to Black et al 2004 (Int. J. Radiat. Oncol. Biol. Phys. 60 1272-1282) Int. J. Radiat. Oncol. Biol. Phys. 62 299-300 author reply 300
CrossRef  PubMed 
 
Beer A J et al 2006 Positron emission tomography using [18F]galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man Clin. Cancer Res. 12 3942-9
CrossRef  PubMed 
 
Bentzen S M 2005 Radiation therapy: intensity modulated, image guided, biologically optimized and evidence based Radiother. Oncol. 77 227-30
CrossRef  PubMed 
 
Beyer T, Antoch G, Blodgett T, Freudenberg L F, Akhurst T and Mueller S 2003 Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology Eur. J. Nucl. Med. Mol. Imaging 30 588-96
CrossRef  PubMed 
 
Beyer T et al 2005 Respiration artifacts in whole-body (18)F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rows Eur. J. Nucl. Med. Mol. Imaging 32 1429-39
CrossRef  PubMed 
 
Black Q C, Grills I S, Kestin L L, Wong C Y, Wong J W, Martinez A A and Yan D 2004 Defining a radiotherapy target with positron emission tomography Int. J. Radiat. Oncol. Biol. Phys. 60 1272-82
CrossRef  PubMed 
 
Boellaard R, Krak N C, Hoekstra O S and Lammertsma A A 2004 Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study J. Nucl. Med. 45 1519-27
PubMed 
 
Bortfeld T, Jiang S B and Rietzel E 2004 Effects of motion on the total dose distribution Semin. Radiat. Oncol. 14 41-51
CrossRef  PubMed 
 
Bradley J, Thorstad W L, Mutic S, Miller T R, Dehdashti F, Siegel B A, Bosch W and Bertrand R J 2004 Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer Int. J. Radiat. Oncol. Biol. Phys. 59 78-86
CrossRef  PubMed 
 
Buck A K et al 2005 Clinical relevance of imaging proliferative activity in lung nodules Eur. J. Nucl. Med. Mol. Imaging 32 525-33
CrossRef  PubMed 
 
Bussink J, Kaanders J H and van der Kogel A J 2003 Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers Radiother. Oncol. 67 3-15
CrossRef  PubMed 
 
Caldwell C B, Mah K, Skinner M and Danjoux C E 2003 Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET Int. J. Radiat. Oncol. Biol. Phys. 55 1381-93
CrossRef  PubMed 
 
Caldwell C B, Mah K, Ung Y C, Danjoux C E, Balogh J M, Ganguli S N and Ehrlich L E 2001 Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion Int. J. Radiat. Oncol. Biol. Phys. 51 923-31
CrossRef  PubMed 
 
Chan S C, Ng S H, Chang J T, Lin C Y, Chen Y C, Chang Y C, Hsu C L, Wang H M, Liao C T and Yen T C 2006 Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging Eur. J. Nucl. Med. Mol. Imaging 33 1032-40
CrossRef  PubMed 
 
Chao K S, Bosch W R, Mutic S, Lewis J S, Dehdashti F, Mintun M A, Dempsey J F, Perez C A, Purdy J A and Welch M J 2001 A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy Int. J. Radiat. Oncol. Biol. Phys. 49 1171-82
CrossRef  PubMed 
 
Chatziioannou A F 2002 PET scanners dedicated to molecular imaging of small animal models Mol. Imaging Biol. 4 47-63
CrossRef  PubMed 
 
Cheson B D 2008 New response criteria for lymphomas in clinical trials Ann Oncol. 19 Suppl 4 iv35-8

 
Ciernik I F, Dizendorf E, Baumert B G, Reiner B, Burger C, Davis J B, Lutolf U M, Steinert H C and Von Schulthess G K 2003 Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study Int. J. Radiat. Oncol. Biol. Phys. 57 853-63
CrossRef  PubMed 
 
Connell C A, Corry J, Milner A D, Hogg A, Hicks R J, Rischin D and Peters L J 2007 Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma Head Neck 29 986-95
CrossRef  PubMed 
 
Daisne J F, Duprez T, Weynand B, Lonneux M, Hamoir M, Reychler H and Gregoire V 2004 Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen Radiology 233 93-100
CrossRef  PubMed 
 
Daisne J F, Sibomana M, Bol A, Doumont T, Lonneux M and Gregoire V 2003 Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms Radiother. Oncol. 69 247-50
CrossRef  PubMed 
 
Davis J B, Reiner B, Huser M, Burger C, Szekely G and Ciernik I F 2006 Assessment of 18F PET signals for automatic target volume definition in radiotherapy treatment planning Radiother. Oncol. 80 43-50
CrossRef  PubMed 
 
Dawood M, Buther F, Lang N, Schober O and Schafers K P 2007 Respiratory gating in positron emission tomography: a quantitative comparison of different gating schemes Med. Phys. 34 3067-76
CrossRef  PubMed 
 
de Koste J R, Lagerwaard F J, de Boer H C, Nijssen-Visser M R and Senan S 2003 Are multiple CT scans required for planning curative radiotherapy in lung tumors of the lower lobe? Int. J. Radiat. Oncol. Biol. Phys. 55 1394-9
CrossRef  PubMed 
 
De Ruysscher D et al 2005 Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study Radiother. Oncol. 77 5-10
CrossRef  PubMed 
 
Dehdashti F, Mintun M A, Lewis J S, Bradley J, Govindan R, Laforest R, Welch M J and Siegel B A 2003 In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM Eur. J. Nucl. Med. Mol. Imaging 30 844-50
CrossRef  PubMed 
 
Dierckx R A and Van de Wiele C 2008 FDG uptake, a surrogate of tumour hypoxia? Eur. J. Nucl. Med. Mol. Imaging 35 1544-9
CrossRef  PubMed 
 
Dresel S, Grammerstorff J, Schwenzer K, Brinkbaumer K, Schmid R, Pfluger T and Hahn K 2003 [18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methods Eur. J. Nucl. Med. Mol. Imaging 30 995-1003
CrossRef  PubMed 
 
Dwamena B A, Sonnad S S, Angobaldo J O and Wahl R L 1999 Metastases from non-small cell lung cancer: mediastinal staging in the 1990s-meta-analytic comparison of PET and CT Radiology 213 530-6
PubMed 
 
Ekberg L, Holmberg O, Wittgren L, Bjelkengren G and Landberg T 1998 What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer? Radiother. Oncol. 48 71-7
CrossRef  PubMed 
 
Erdi Y E, Mawlawi O, Larson S M, Imbriaco M, Yeung H, Finn R and Humm J L 1997 Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding Cancer 80 2505-9
CrossRef  PubMed 
 
Eschmann S M, Friedel G, Paulsen F, Reimold M, Hehr T, Scheiderbauer J, Budach W, Kotzerke J and Bares R 2007 Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors Eur. J. Nucl. Med. Mol. Imaging 34 54-9
CrossRef  PubMed 
 
Eschmann S M, Paulsen F, Reimold M, Dittmann H, Welz S, Reischl G, Machulla H J and Bares R 2005 Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy J. Nucl. Med. 46 253-60
PubMed 
 
Evans P M 2008 Topical review: Anatomical imaging for radiotherapy Phys. Med. Biol. 53 R151-91
IOPscience 
 
Ford E C, Kinahan P E, Hanlon L, Alessio A, Rajendran J, Schwartz D L and Phillips M 2006 Tumor delineation using PET in head and neck cancers: threshold contouring and lesion volumes Med. Phys. 33 4280-8
CrossRef  PubMed 
 
Gambhir S S, Czernin J, Schwimmer J, Silverman D H, Coleman R E and Phelps M E 2001 A tabulated summary of the FDG PET literature J. Nucl. Med. 42 1S-93S
PubMed 
 
Geets X, Daisne J F, Gregoire V, Hamoir M and Lonneux M 2004 Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT Radiother. Oncol. 71 267-73
CrossRef  PubMed 
 
Geets X, Lee J A, Bol A, Lonneux M and Gregoire V 2007 A gradient-based method for segmenting FDG-PET images: methodology and validation Eur. J. Nucl. Med. Mol. Imaging 34 1427-38
CrossRef  PubMed 
 
Goerres G W, Kamel E, Heidelberg T N, Schwitter M R, Burger C and von Schulthess G K 2002 PET-CT image co-registration in the thorax: influence of respiration Eur. J. Nucl. Med. Mol. Imaging 29 351-60
CrossRef  PubMed 
 
Goshen E, Davidson T, Yahalom R, Talmi Y P and Zwas S T 2006 PET/CT in the evaluation of patients with squamous cell cancer of the head and neck Int. J. Oral Maxillofac. Surg. 35 332-6
CrossRef  PubMed 
 
Graves E E, Quon A and Loo B W Jr 2007 RT_Image: an open-source tool for investigating PET in radiation oncology Technol. Cancer Res. Treat. 6 111-21
PubMed 
 
Grgic A, U N, Schaefer A, S K, Kirsch C M and Hellwig D 2008 FDG-PET-based radiotherapy planning in lung cancer: optimum breathing protocol and patient positioning-an intraindividual comparison Int. J. Radiat. Oncol. Biol. Phys. DOI: 10.1016/j.ijrobp.2008.03.063

 
Grosu A L, Feldmann H, Dick S, Dzewas B, Nieder C, Gumprecht H, Frank A, Schwaiger M, Molls M and Weber W A 2002 Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas Int. J. Radiat. Oncol. Biol. Phys. 54 842-54
CrossRef 
 
Grosu A L, Lachner R, Wiedenmann N, Stark S, Thamm R, Kneschaurek P, Schwaiger M, Molls M and Weber W A 2003 Validation of a method for automatic image fusion (BrainLAB System) of CT data and 11C-methionine-PET data for stereotactic radiotherapy using a LINAC: first clinical experience Int. J. Radiat. Oncol. Biol. Phys. 56 1450-63
CrossRef  PubMed 
 
Grosu A L et al 2007 Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer Int. J. Radiat. Oncol. Biol. Phys. 69 541-51
CrossRef  PubMed 
 
Grosu A L, Weber W, Feldmann H J, Wuttke B, Bartenstein P, Gross M W, Lumenta C, Schwaiger M and Molls M 2000 First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas Int. J. Radiat. Oncol. Biol. Phys. 47 517-26
CrossRef  PubMed 
 
Grosu A L, Weber W A, Franz M, Stark S, Piert M, Thamm R, Gumprecht H, Schwaiger M, Molls M and Nieder C 2005 Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 63 511-9
CrossRef  PubMed 
 
Grosu A L, Weber W A, Riedel E, Jeremic B, Nieder C, Franz M, Gumprecht H, Jaeger R, Schwaiger M and Molls M 2005 L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 63 64-74
CrossRef  PubMed 
 
Hellwig D, Graeter T P, Ukena D, Groeschel A, Sybrecht G W, Schaefers H J and Kirsch C M 2007 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense? J. Nucl. Med. 48 1761-6
CrossRef  PubMed 
 
Hentschel M 2007 Möglichkeiten und Grenzen der modernen Schnittbildverfahren (CT, MRT, PET) in der molekularen Bildgebung Der Nuklearmediziner. 30 31-41
CrossRef 
 
Hill D L, Batchelor P G, Holden M and Hawkes D J 2001 Medical image registration Phys. Med. Biol. 46 R1-45
IOPscience 
 
Humm J L, Rosenfeld A and Del Guerra A 2003 From PET detectors to PET scanners Eur. J. Nucl. Med. Mol. Imaging 30 1574-97
CrossRef  PubMed 
 
ICRU 1999 Prescribing, recording and reporting photon beam therapy. Supplement to report 50

 
ICRU 1993 Prescribing, recording and reporting photon beam therapy

 
Ireland R H, Dyker K E, Barber D C, Wood S M, Hanney M B, Tindale W B, Woodhouse N, Hoggard N, Conway J and Robinson M H 2007 Nonrigid image registration for head and neck cancer radiotherapy treatment planning with PET/CT Int. J. Radiat. Oncol. Biol. Phys. 68 952-7
CrossRef  PubMed 
 
Jaskowiak C J, Bianco J A, Perlman S B and Fine J P 2005 Influence of reconstruction iterations on 18F-FDG PET/CT standardized uptake values J. Nucl. Med. 46 424-8
PubMed 
 
Jeong H J, Min J J, Park J M, Chung J K, Kim B T, Jeong J M, Lee D S, Lee M C, Han S K and Shim Y S 2002 Determination of the prognostic value of [18F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer Nucl. Med. Commun. 23 865-70
CrossRef  PubMed 
 
Keall P J, Kini V R, Vedam S S and Mohan R 2001 Motion adaptive x-ray therapy: a feasibility study Phys. Med. Biol. 46 1-10
IOPscience 
 
Keall P J et al 2006 The management of respiratory motion in radiation oncology report of AAPM Task Group 76 Med. Phys. 33 3874-900
CrossRef  PubMed 
 
Kirby A M and Mikhaeel N G 2007 The role of FDG PET in the management of lymphoma: what is the evidence base? Nucl. Med. Commun. 28 335-54
CrossRef  PubMed 
 
Kiricuta I C 2001 Selection and delineation of lymph node target volume for lung cancer conformal radiotherapy. Proposal for standardizing terminology based on surgical experience Strahlenther. Onkol. 177 410-23
CrossRef  PubMed 
 
Knight S B, Delbeke D, Stewart J R and Sandler M P 1996 Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy Chest 109 982-8
CrossRef  PubMed 
 
Koh W J et al 1995 Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography Int. J. Radiat. Oncol. Biol. Phys. 33 391-8
CrossRef  PubMed 
 
Koritzinsky M, Seigneuric R, Magagnin M G, van den Beucken T, Lambin P and Wouters B G 2005 The hypoxic proteome is influenced by gene-specific changes in mRNA translation Radiother. Oncol. 76 177-86
CrossRef  PubMed 
 
Kracht L W, Miletic H, Busch S, Jacobs A H, Voges J, Hoevels M, Klein J C, Herholz K and Heiss W D 2004 Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology Clin. Cancer Res. 10 7163-70
CrossRef  PubMed 
 
Langen K J, Ziemons K, Kiwit J C, Herzog H, Kuwert T, Bock W J, Stocklin G, Feinendegen L E and Muller-Gartner H W 1997 3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET J. Nucl. Med. 38 517-22
PubMed 
 
Langen K M and Jones D T 2001 Organ motion and its management Int. J. Radiat. Oncol. Biol. Phys. 50 265-78
CrossRef  PubMed 
 
Lee N Y et al 2008 Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study Int. J. Radiat. Oncol. Biol. Phys. 70 2-13
CrossRef  PubMed 
 
Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U and Joensuu H 1993 Influence of the blood glucose concentration on FDG uptake in cancer-a PET study J. Nucl. Med. 34 1-6
PubMed 
 
Ling C C, Humm J, Larson S, Amols H, Fuks Z, Leibel S and Koutcher J A 2000 Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality Int. J. Radiat. Oncol. Biol. Phys. 47 551-60
CrossRef  PubMed 
 
Ling C C, Yorke E, Amols H, Mechalakos J, Erdi Y, Leibel S, Rosenzweig K and Jackson A 2004 High-tech will improve radiotherapy of NSCLC: a hypothesis waiting to be validated Int. J. Radiat. Oncol. Biol. Phys. 60 3-7
CrossRef 
 
Liu T, Xu W, Yan W L, Ye M, Bai Y R and Huang G 2007 FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review Radiother. Oncol. 85 327-35
CrossRef  PubMed 
 
Livieratos L, Rajappan K, Stegger L, Schafers K, Bailey D L and Camici P G 2006 Respiratory gating of cardiac PET data in list-mode acquisition Eur. J. Nucl. Med. Mol. Imaging 33 584-8
CrossRef  PubMed 
 
MacManus M P, Bayne M, Fimmell N, Reynolds J, Everitt S, Ball D, Pitman A, Ware R, Lau E and R H 2007 Reproducibility of “Intelligent” Contouring of Gross Tumor Volume in Non-Small Cell Lung Cancer on PET/CT Images Using a Standardized Visual Method Internat J. Radiat. Oncol. Biol. Phys. 69 S154-5
CrossRef 
 
MacManus M P and Hicks R J 2008 Where do we draw the line? Contouring tumors on positron emission tomography/computed tomography Int. J. Radiat. Oncol. Biol. Phys. 71 2-4
CrossRef  PubMed 
 
MacManus M P, Hicks R J, Matthews J P, Hogg A, McKenzie A F, Wirth A, Ware R E and Ball D L 2001 High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy Int. J. Radiat. Oncol. Biol. Phys. 50 287-93
CrossRef  PubMed 
 
Madani I et al 2007 Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer Int. J. Radiat. Oncol. Biol. Phys. 68 126-35
CrossRef  PubMed 
 
Menda Y, Bushnell D L, Madsen M T, McLaughlin K, Kahn D and Kernstine K H 2001 Evaluation of various corrections to the standardized uptake value for diagnosis of pulmonary malignancy Nucl. Med. Commun. 22 1077-81
CrossRef  PubMed 
 
Milker-Zabel S, Zabel-du Bois A, Henze M, Huber P, Schulz-Ertner D, Hoess A, Haberkorn U and Debus J 2006 Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET Int. J. Radiat. Oncol. Biol. Phys. 65 222-7
CrossRef  PubMed 
 
Miwa K et al 2008 Simultaneous integrated boost technique by helical tomotherapy for the treatment of glioblastoma multiforme with 11C-methionine PET: report of three cases J. Neurooncol. 87 333-9
CrossRef  PubMed 
 
Mix M and Kremp S 2008 PET in der Strahlentherapie: Zielvolumen Der Nuklearmediziner. in press

 
Muehllehner G and Karp J S 2006 Positron emission tomography Phys. Med. Biol. 51 R117-37
IOPscience 
 
Munley M T, Marks L B, Scarfone C, Sibley G S, Patz E F Jr, Turkington T G, Jaszczak R J, Gilland D R, Anscher M S and Coleman R E 1999 Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects Lung Cancer 23 105-14
CrossRef  PubMed 
 
Nakamoto Y, Tatsumi M, Hammoud D, Cohade C, Osman M M and Wahl R L 2005 Normal FDG distribution patterns in the head and neck: PET/CT evaluation Radiology 234 879-85
CrossRef  PubMed 
 
Nehmeh S A, Erdi Y E, Ling C C, Rosenzweig K E, Schoder H, Larson S M, Macapinlac H A, Squire O D and Humm J L 2002 Effect of respiratory gating on quantifying PET images of lung cancer J. Nucl. Med. 43 876-81
PubMed 
 
Nehmeh S A et al 2004 Four-dimensional (4D) PET/CT imaging of the thorax Med. Phys. 31 3179-86
CrossRef  PubMed 
 
Nehmeh S A et al 2008 Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer Int. J. Radiat. Oncol. Biol. Phys. 70 235-42
CrossRef  PubMed 
 
Nestle U, Hellwig D, Schmidt S, Licht N, Walter K, Ukena D, Rübe C, Baumann M and Kirsch C M 2002 2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography in target volume definition for radiotherapy of patients with non-small-cell lung cancer Mol. Imaging Biol. 4 257-63
CrossRef  PubMed 
 
Nestle U, Kremp S and Grosu A 2006 Practical integration of [(18)F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): The technical basis, ICRU-target volumes, problems, perspectives Radiother. Oncol. 81 209-225
CrossRef  PubMed 
 
Nestle U, Kremp S, Schaefer-Schuler A, Sebastian-Welsch C, Hellwig D, Rübe C and Kirsch C M 2005 Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer J. Nucl. Med. 46 1342-8
PubMed 
 
Nestle U, Schaefer-Schuler A, Kremp S, Groeschel A, Hellwig D, Rube C and Kirsch C M 2007 Target volume definition for (18)F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer Eur. J. Nucl. Med. Mol. Imaging 34 453-462
CrossRef  PubMed 
 
Nestle U et al 1999 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis Int. J. Radiat. Oncol. Biol. Phys. 44 593-7
CrossRef  PubMed 
 
Nishioka T et al 2002 Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas Int. J. Radiat. Oncol. Biol. Phys. 53 1051-7
CrossRef  PubMed 
 
Nordsmark M et al 2005 Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study Radiother. Oncol. 77 18-24
CrossRef  PubMed 
 
Nutt R 2002 The history of Positron emission tomography Mol. Imaging Biol. 4 11-26
CrossRef  PubMed 
 
Paquet N, Albert A, Foidart J and Hustinx R 2004 Within-patient variability of 18F-FDG: standardized uptake values in normal tissues J. Nucl. Med. 45 784-8
PubMed 
 
Park S J, Ionascu D, Killoran J, Mamede M, Gerbaudo V H, Chin L and Berbeco R 2008 Evaluation of the combined effects of target size, respiratory motion and background activity on 3D and 4D PET/CT images Phys. Med. Biol. 53 3661-79
IOPscience 
 
Paulino A C and Johnstone P A 2004 FDG-PET in radiotherapy treatment planning: Pandora's box? Int. J. Radiat. Oncol. Biol. Phys. 59 4-5
CrossRef  PubMed 
 
Paulino A C, Koshy M, Howell R, Schuster D and Davis L W 2005 Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer Int. J. Radiat. Oncol. Biol. Phys. 61 1385-92
CrossRef  PubMed 
 
Plathow C and Weber W A 2008 Tumor cell metabolism imaging J. Nucl. Med. 49 (Suppl 2) 43S-63S
CrossRef  PubMed 
 
Plotkin M, Gneveckow U, Meier-Hauff K, Amthauer H, Feussner A, Denecke T, Gutberlet M, Jordan A, Felix R and Wust P 2006 18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma Int. J. Hyperthermia. 22 319-25
CrossRef  PubMed 
 
Ponisch F, Richter C, Just U and Enghardt W 2008 Attenuation correction of four dimensional (4D) PET using phase-correlated 4D-computed tomography Phys. Med. Biol. 53 N259-68
IOPscience 
 
Pötzsch C, Hofheinz F and van den Hoff J 2006 Vergleich der Inter-Observer-Variabilität bei manueller und automatischer Volumenbestimmung in der PET Nuklearmedizin 45 A42

 
Rahn A N, Baum R P, Adamietz I A, Adams S, Sengupta S, Mose S, Bormeth S B, Hor G and Bottcher H D 1998 Value of 18F fluorodeoxyglucose positron emission tomography in radiotherapy planning of head-neck tumors Strahlenther Onkol. 174 358-64
CrossRef  PubMed 
 
Rasey J S, Koh W J, Evans M L, Peterson L M, Lewellen T K, Graham M M and Krohn K A 1996 Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients Int. J. Radiat. Oncol. Biol. Phys. 36 417-28
CrossRef  PubMed 
 
Rosenzweig K E et al 2000 The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer Int. J. Radiat. Oncol. Biol. Phys. 48 81-7
CrossRef  PubMed 
 
Rosenzweig K E, Sura S, Jackson A and Yorke E 2007 Involved-field radiation therapy for inoperable non small-cell lung cancer J. Clin. Oncol.

 
Ross C S, Hussey D H, Pennington E C, Stanford W and Doornbos J F 1990 Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography Int. J. Radiat. Oncol. Biol. Phys. 18 671-7
CrossRef  PubMed 
 
Sanchez-Crespo A, Andreo P and Larsson S A 2004 Positron flight in human tissues and its influence on PET image spatial resolution Eur. J. Nucl. Med. Mol. Imaging 31 44-51
CrossRef  PubMed 
 
Scarfone C, Lavely W C, Cmelak A J, Delbeke D, Martin W H, Billheimer D and Hallahan D E 2004 Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging J. Nucl. Med. 45 543-52
PubMed 
 
Schaefer A, Kremp S, Hellwig D, Rube C and Kirsch C M 2008 Target volumes derived from FDG-PET in lung cancer: Phantom measurements for delineation of contours Eur. J. Nucl. Med. in press

 
Schinagl D A, Vogel W V, Hoffmann A L, van Dalen J A, Oyen W J and Kaanders J H 2007 Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer Int. J. Radiat. Oncol. Biol. Phys. 69 1282-9
CrossRef  PubMed 
 
Schoder H et al 2006 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI J. Nucl. Med. 47 755-62
PubMed 
 
Schoder H, Erdi Y E, Chao K, Gonen M, Larson S M and Yeung H W 2004 Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients J. Nucl. Med. 45 559-66
PubMed 
 
Schwartz D L et al 2005 FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma Int. J. Radiat. Oncol. Biol. Phys. 61 129-36
CrossRef  PubMed 
 
Senan S, Chapet O, Lagerwaard F J and Ten Haken R K 2004 Defining target volumes for non-small cell lung carcinoma Semin. Radiat. Oncol. 14 308-14
CrossRef  PubMed 
 
Senan S, De Ruysscher D, Giraud P, Mirimanoff R and Budach V 2004 Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer Radiother. Oncol. 71 139-46
CrossRef  PubMed 
 
Shields A F, Grierson J R, Dohmen B M, Machulla H J, Stayanoff J C, Lawhorn-Crews J M, Obradovich J E, Muzik O and Mangner T J 1998 Imaging proliferation in vivo with [F-18]FLT and positron emission tomography Nat. Med. 4 1334-6
CrossRef  PubMed 
 
Shirato H, Seppenwoolde Y, Kitamura K, Onimura R and Shimizu S 2004 Intrafractional tumor motion: lung and liver Semin. Radiat. Oncol. 14 10-8
CrossRef  PubMed 
 
Steenbakkers R J et al 2006 Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis Int. J. Radiat. Oncol. Biol. Phys. 64 435-48
CrossRef  PubMed 
 
Sura S, Greco C, Gelblum D, Yorke E D, Jackson A and Rosenzweig K E 2008 (18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy Int. J. Radiat. Oncol. Biol. Phys. 70 1397-402
CrossRef  PubMed 
 
Tanderup K, Olsen D R and Grau C 2006 Dose painting: Art or science? Radiother. Oncol. 79 245-8
CrossRef  PubMed 
 
Tarantola G, Zito F and Gerundini P 2003 PET Instrumentation and Reconstruction Algorithms in Whole-Body Applications J. Nucl. Med. 44 756-769
PubMed 
 
Troost E G, Bussink J, Kaanders J H, van Eerd J, Peters J P, Rijken P F, Boerman O C and van der Kogel A J 2005 Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines Radiother. Oncol. 76 194-9
CrossRef  PubMed 
 
Van de Steene J, Linthout N, de Mey J, Vinh-Hung V, Claassens C, Noppen M, Bel A and Storme G 2002 Definition of gross tumor volume in lung cancer: inter-observer variability Radiother. Oncol. 62 37-49
CrossRef  PubMed 
 
van Tinteren H et al 2002 Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial Lancet 359 1388-93
CrossRef  PubMed 
 
Visvikis D and Ell P J 2003 Impact of technology on the utilisation of positron emission tomography in lymphoma: current and future perspectives Eur. J. Nucl. Med. Mol. Imaging 30 (Suppl 1) S106-16
CrossRef  PubMed 
 
von Schulthess G K, Steinert H C and Hany T F 2006 Integrated PET/CT: current applications and future directions Radiology 238 405-22
CrossRef  PubMed 
 
Weber W A, Dick S, Reidl G, Dzewas B, Busch R, Feldmann H J, Molls M, Lumenta C B, Schwaiger M and Grosu A L 2001 Correlation between postoperative 3-[(123)I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas J. Nucl. Med. 42 1144-50
PubMed 
 
Weber W A, Grosu A L and Czernin J 2008 Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning Nat. Clin. Pract. Oncol. 5 160-70
CrossRef  PubMed 
 
Weber W A, Wester H J, Grosu A L, Herz M, Dzewas B, Feldmann H J, Molls M, Stocklin G and Schwaiger M 2000 O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study Eur J. Nucl. Med. 27 542-9
CrossRef 
 
Wieler H J and Coleman R E 2000 PET in clinical oncology

 
Wienhard K, Eriksson L, Grootoonk S, Casey M, Pietrzyk U and Heiss W D 1992 Performance evaluation of the positron scanner ECAT EXACT J. Comput. Assist. Tomogr. 16 804-13
CrossRef  PubMed 
 
Wienhard K, Wagner R and Heiss W D 1989 PET Grundlagen und Anwendungen der Positronen Emissions Tomographie

 
Williams K J et al 2005 Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1 Radiother. Oncol. 75 89-98
CrossRef  PubMed 
 
Yap C S, Czernin J, Fishbein M C, Cameron R B, Schiepers C, Phelps M E and Weber W A 2006 Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography Chest 129 393-401
CrossRef  PubMed 
 
Yaromina A, Holscher T, Eicheler W, Rosner A, Krause M, Hessel F, Petersen C, Thames H D, Baumann M and Zips D 2005 Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma? Radiother. Oncol. 76 206-12
CrossRef  PubMed 
 
Zhang T, Jeraj R, Keller H, Lu W, Olivera G H, McNutt T R, Mackie T R and Paliwal B 2004 Treatment plan optimization incorporating respiratory motion Med. Phys. 31 1576-86
CrossRef  PubMed 
 
Zimny M, Hochstenbag M, Lamers R, Reinartz P, Cremerius U, Ten Velde G and Büll U 2003 Mediastinal staging of lung cancer with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography and a dual-head coincidence gamma camera Eur. Radiol. 13 740-7
PubMed 
crossref member

Related review articles

What's this?
View review articles related to this research to gain an insight into the key trends in this subject area. Related review articles are selected based on PACS/MSC codes, and are no more than three years old.

  1. The history of IRPA—up to the millennium
  2. Malignant pleural mesothelioma risk among nuclear workers: a review

View by subject




Export








Please login to access our web services, or create an account if you don't yet have one.

You must have cookies enabled in your web browser to be able to login.

Username
Password

Forgotten your password? Get a new one here.